Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
According to FDA regulatory status, these peptides are not FDA-approved for human use and are intended for research use only
This is not a UnitedHealthcare policy decision but a federal statute
In pre-clinical research, DSIP is often used to examine neurotransmitter interaction, sleep-cycle signaling markers, and stress-response modulation pathways
Product Name: Retatrutide Unit Size: Multiple vial sizes available Other Names: Retatrutide, LY3437943, Reta (informal) Form: Lyophilized solid The compound was characterized in a Phase 2 randomized trial published in the New England Journal of Medicine in 2023, which documented a mean body weight reduction of 24.2% at 48 weeks in the highest-dose arm, against 2.1% in the placebo arm
Research shows that patients lose more weight, and sustain that loss, if they receive care guided by a provider trained in obesity medicine, and wraparound services, in addition to a prescription for a weight management medication
&srotate=0)
US$ 28.38
US$ 20.45
US$ 27.21
US$ 29.66
US$ 20.37
US$ 26.10
US$ 23.54
